Immunotherapy before surgery offers a potential new treatment for rare cancer
An early phase clinical trial published in Nature Medicine show that patients with mesothelioma - a rare cancer of the lining of the lung - who received a combination of two immunotherapy drugs before surgery had successful surgeries and encouraging early outcomes